IE36867B1 - Potentiated antimicrobial compositions - Google Patents

Potentiated antimicrobial compositions

Info

Publication number
IE36867B1
IE36867B1 IE1103/72A IE110372A IE36867B1 IE 36867 B1 IE36867 B1 IE 36867B1 IE 1103/72 A IE1103/72 A IE 1103/72A IE 110372 A IE110372 A IE 110372A IE 36867 B1 IE36867 B1 IE 36867B1
Authority
IE
Ireland
Prior art keywords
aug
alkyl
optionally substituted
competitor
specified
Prior art date
Application number
IE1103/72A
Other languages
English (en)
Other versions
IE36867L (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IE36867L publication Critical patent/IE36867L/xx
Publication of IE36867B1 publication Critical patent/IE36867B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IE1103/72A 1971-08-05 1972-08-04 Potentiated antimicrobial compositions IE36867B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3677471 1971-08-05
GB3581772A GB1405246A (en) 1971-08-05 1972-08-01 Potentiated antimicrobial compositions

Publications (2)

Publication Number Publication Date
IE36867L IE36867L (en) 1973-02-05
IE36867B1 true IE36867B1 (en) 1977-03-16

Family

ID=26262869

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1103/72A IE36867B1 (en) 1971-08-05 1972-08-04 Potentiated antimicrobial compositions

Country Status (14)

Country Link
JP (1) JPS6036409B2 (xx)
BE (1) BE787236A (xx)
CS (1) CS172956B2 (xx)
DE (1) DE2238536C2 (xx)
FR (1) FR2150733B1 (xx)
GB (1) GB1405246A (xx)
HU (1) HU170534B (xx)
IE (1) IE36867B1 (xx)
IL (1) IL40050A (xx)
IT (1) IT1057861B (xx)
LU (1) LU65857A1 (xx)
NL (1) NL7210719A (xx)
NO (1) NO139004C (xx)
SE (1) SE434337B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451043A (en) * 1972-08-01 1976-09-29 Wellcome Found Biologicylly acitve compounds and compositions
GB1454165A (en) * 1972-08-01 1976-10-27 Wellcome Found Biologically active compounds and compositions
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
GB1596044A (en) * 1977-04-14 1981-08-19 Wellcome Found Veterinary compositions
AU572792B2 (en) * 1982-09-20 1988-05-19 Wellcome Foundation Limited, The 2-amino, 4-oxo-pteridine derivatives
JPS63121616U (xx) * 1987-01-30 1988-08-08
CN113897413A (zh) * 2021-10-12 2022-01-07 广州达安基因股份有限公司 一种体外诊断试剂防腐剂及其用途

Also Published As

Publication number Publication date
GB1405246A (en) 1975-09-10
DE2238536A1 (de) 1973-02-22
NO139004C (no) 1978-12-20
NO139004B (no) 1978-09-11
IL40050A0 (en) 1972-10-29
NL7210719A (xx) 1973-02-07
SE434337B (sv) 1984-07-23
IT1057861B (it) 1982-03-30
HU170534B (xx) 1977-06-28
FR2150733B1 (xx) 1975-06-20
BE787236A (fr) 1973-02-05
JPS4828610A (xx) 1973-04-16
DE2238536C2 (de) 1984-11-29
LU65857A1 (xx) 1973-02-01
FR2150733A1 (xx) 1973-04-13
JPS6036409B2 (ja) 1985-08-20
IE36867L (en) 1973-02-05
IL40050A (en) 1976-02-29
CS172956B2 (xx) 1977-01-28

Similar Documents

Publication Publication Date Title
CA2173150A1 (en) Novel peptide derivatives
WO2001077107A8 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
US4241056A (en) Penicillins and salts thereof
IE36867L (en) Potentiated antimicrobial compositions
IE37452L (en) Diamino-benzylpyrimidines
ES8602751A1 (es) Procedimiento para la preparacion de derivados de pirimidina
KR940011465A (ko) 약제학적 화합물
AU547792B2 (en) Pyrimido(5,4-d)pyrimidines
GB1198688A (en) Pyrazinoylguanidines
IE820270L (en) Pyrimidone derivatives
GB1315901A (en) Benzothieno 3,3-d- and benzofuro 3,2-d pyrimidines inhibitors of platelet aggregation
IE40523L (en) Benzylpyrimidine derivatives
GB1346710A (en) Antibacterial compositions
GB1072414A (en) New dihydrothieno(3,2-d)pyrimidines
GB1433270A (en) Benzopyrano-2,3-c-pyrazolecarboxylic acids their preparation and compositions containing them
GB1129084A (en) Novel pyrido[2,3-d]pyrimidines
GB1152883A (en) 4,5-Polymethylene-Pyrimidine Derivatives
IE33345L (en) Isothiazolopyrimidines.
GB1526210A (en) Ethylenediamineplatinum(ii)-2,4-dioxopyrimidine complexes
GB1333311A (en) N-bridged bicyclic heteroaromatic compounds
IE33406L (en) Quinazolines
GB1357733A (en) 1,2,4-oxadiazole derivatives
GB1451043A (en) Biologicylly acitve compounds and compositions
IE41192L (en) Potentiated microbial compositions
IE33446L (en) Isothiocyano-diphenylamines